ℹ️
🇬🇧
Search
Search for people relevant for "in-vivo"
in-vivo
Person
Class
Person
Publication
Programmes
prof. PharmDr. Tomáš Šimůnek Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
15 classes
162 publications
Classes
class
Molecular Biology
+6
GAF144 |
Faculty of Pharmacy in Hradec Králové
class
Molecular Biology and Genetics
+5
GAF370 |
Faculty of Pharmacy in Hradec Králové
class
Molecular Basis of Pharmacology and Toxicology
+1
GDEFX05 |
Faculty of Pharmacy in Hradec Králové
Load more classes (5)
Publications
publication
Amino acid derivatives as transdermal permeation enhancers
2013 |
Faculty of Pharmacy in Hradec Králové
publication
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity
2011 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
2009 |
Central Library of Charles University
publication
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo
2008 |
Central Library of Charles University
publication
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity
2007 |
Publication without faculty affiliation
publication
The Effects of Repeated Administration of Pyridoxal Isonicotinoyl Hydrazone (A New Iron Chelator) on the Cardiovascular System in Rabbits
2000 |
Faculty of Pharmacy in Hradec Králové
publication
Hydrophobicity-enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells
2023 |
Faculty of Pharmacy in Hradec Králové
publication
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase II beta Interactions
2021 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Load more publications (152)
Loading network view...